News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com5d agoneutral
Pfizer Bets on Cancer and Weight-Loss Drugs in Post-Pandemic Second ActInvestor's Business Daily5d agoneutral
Pfizer Hikes Guidance On Solid Third Quarter, Names Company Vet As New CFOInvesting.com5d agoneutral
Pfizer increases annual profit forecast amid solid demand for blood thinner drugStockStory5d agoneutral
Pfizer (NYSE:PFE) reports strong Q3 2026, full-year outlook slightly exceeds expectationsInvesting.com5d agoneutral
Pfizer increases annual profit forecast amid solid demand for blood thinner drugMT Newswires5d agobearish
Pfizer Fiscal Q3 Adjusted Earnings Flat, Revenue Falls; Raises 2026 GuidanceBusiness Wire5d agoneutral
Pfizer Reports Strong Third-Quarter 2026 Results And Raises 2026 Guidance